{
    "eid": "2-s2.0-85098232848",
    "title": "Efficacy and safety of oral panobinostat plus subcutaneous bortezomib and oral dexamethasone in patients with relapsed or relapsed and refractory multiple myeloma (PANORAMA 3): an open-label, randomised, phase 2 study",
    "cover-date": "2021-01-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Oncology",
            "@code": "2730",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [],
    "authors": [
        "Jacob P. Laubach",
        "Fredrik Schjesvold",
        "M\u00e1rio Mariz",
        "Meletios A. Dimopoulos",
        "Ewa Lech-Maranda",
        "Ivan Spicka",
        "Vania T.M. Hungria",
        "Tatiana Shelekhova",
        "Andre Abdo",
        "Lutz Jacobasch",
        "Chantana Polprasert",
        "Roman H\u00e1jek",
        "\u00c1rp\u00e1d Ill\u00e9s",
        "Tomasz Wr\u00f3bel",
        "Anna Sureda",
        "Meral Beksac",
        "Iara Z. Gon\u00e7alves",
        "Joan Blad\u00e9",
        "S. Vincent Rajkumar",
        "Ajai Chari",
        "Sagar Lonial",
        "Andrew Spencer",
        "Pierre Maison-Blanche",
        "Philippe Moreau",
        "Jesus F. San-Miguel",
        "Paul G. Richardson"
    ],
    "citedby-count": 36,
    "ref-count": 28,
    "ref-list": [
        "Improved survival in multiple myeloma and the impact of novel therapies",
        "Management of relapsed multiple myeloma: recommendations of the International Myeloma Working Group",
        "Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: a multicenter international myeloma working group study",
        "PANORAMA 2: panobinostat in combination with bortezomib and dexamethasone in patients with relapsed and bortezomib-refractory myeloma",
        "FARYDAK prescribing information",
        "Farydak product characteristics",
        "Panobinostat plus bortezomib and dexamethasone in previously treated multiple myeloma: outcomes by prior treatment",
        "Panobinostat plus bortezomib and dexamethasone versus placebo plus bortezomib and dexamethasone in patients with relapsed or relapsed and refractory multiple myeloma: a multicentre, randomised, double-blind phase 3 trial",
        "Subcutaneous versus intravenous administration of bortezomib in patients with relapsed multiple myeloma: a randomised, phase 3, non-inferiority study",
        "Update on the optimal use of bortezomib in the treatment of multiple myeloma",
        "International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma",
        "Consensus recommendations for the uniform reporting of clinical trials: report of the International Myeloma Workshop Consensus Panel 1",
        "Developments in continuous therapy and maintenance treatment approaches for patients with newly diagnosed multiple myeloma",
        "Phase II trial of single-agent panobinostat consolidation improves responses after sub-optimal transplant outcomes in multiple myeloma",
        "Randomized phase 2 study: elotuzumab plus bortezomib/dexamethasone vs bortezomib/dexamethasone for relapsed/refractory MM",
        "Pomalidomide, bortezomib, and dexamethasone for patients with relapsed or refractory multiple myeloma previously treated with lenalidomide (OPTIMISMM): a randomised, open-label, phase 3 trial",
        "Interpreting clinical trial data in multiple myeloma: translating findings to the real-world setting",
        "Panobinostat for the treatment of relapsed or relapsed/refractory multiple myeloma: pharmacology and clinical outcomes",
        "Mechanism of action of proteasome inhibitors and deacetylase inhibitors and the biological basis of synergy in multiple myeloma",
        "Phase I, open-label study of panobinostat, lenalidomide, bortezomib + dexamethasone in relapsed and relapsed/refractory multiple myeloma",
        "Phase I/II study of the combination of panobinostat and carfilzomib in patients with relapsed/refractory multiple myeloma",
        "A phase 2 study of panobinostat with lenalidomide and weekly dexamethasone in myeloma",
        "Bortezomib, thalidomide, dexamethasone, and panobinostat for patients with relapsed multiple myeloma (MUK-six): a multicentre, open-label, phase 1/2 trial",
        "Elotuzumab plus pomalidomide and dexamethasone for multiple myeloma",
        "Isatuximab plus pomalidomide and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (ICARIA-MM): a randomised, multicentre, open-label, phase 3 study",
        "Daratumumab plus pomalidomide and dexamethasone in relapsed and/or refractory multiple myeloma",
        "Pomalidomide, dexamethasone, and daratumumab in relapsed refractory multiple myeloma after lenalidomide treatment",
        "Controversy in the use of CD38 antibody for treatment of myeloma: is high CD38 expression good or bad?"
    ],
    "affiliation": [
        {
            "affiliation-city": "Debrecen",
            "@id": "60108571",
            "affilname": "\u00c1ltal\u00e1nos Orvostudom\u00e1nyi Kar",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60108571",
            "affiliation-country": "Hungary"
        },
        {
            "affiliation-city": "Oslo",
            "@id": "60105037",
            "affilname": "Oslo Universitetssykehus",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60105037",
            "affiliation-country": "Norway"
        },
        {
            "affiliation-city": "Warsaw",
            "@id": "60073843",
            "affilname": "Institute of Haematology and Transfusion Medicine, Warsaw",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60073843",
            "affiliation-country": "Poland"
        },
        {
            "affiliation-city": "Ostrava",
            "@id": "60068908",
            "affilname": "University Hospital in Ostrava",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60068908",
            "affiliation-country": "Czech Republic"
        },
        {
            "affiliation-city": "Athens",
            "@id": "60067083",
            "affilname": "School of Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60067083",
            "affiliation-country": "Greece"
        },
        {
            "affiliation-city": "Pamplona",
            "@id": "60032489",
            "affilname": "The Cima Universidad de Navarra",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60032489",
            "affiliation-country": "Spain"
        },
        {
            "affiliation-city": "Barcelona",
            "@id": "60030315",
            "affilname": "Hospital Clinic Barcelona",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60030315",
            "affiliation-country": "Spain"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Nantes",
            "@id": "60025861",
            "affilname": "H\u00f4tel Dieu CHU de Nantes",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60025861",
            "affiliation-country": "France"
        },
        {
            "affiliation-city": "Paris",
            "@id": "60022785",
            "affilname": "H\u00f4pital Bichat-Claude-Bernard AP-HP",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022785",
            "affiliation-country": "France"
        },
        {
            "affiliation-city": "Saratov",
            "@id": "60022695",
            "affilname": "Saratov State Medical University named after V. I. Razumovsky",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022695",
            "affiliation-country": "Russian Federation"
        },
        {
            "affiliation-city": "Melbourne",
            "@id": "60019578",
            "affilname": "Monash University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60019578",
            "affiliation-country": "Australia"
        },
        {
            "affiliation-city": "Prague",
            "@id": "60016605",
            "affilname": "Charles University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60016605",
            "affiliation-country": "Czech Republic"
        },
        {
            "affiliation-city": "New York",
            "@id": "60012981",
            "affilname": "Icahn School of Medicine at Mount Sinai",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60012981",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Ankara",
            "@id": "60012603",
            "affilname": "Ankara \u00dcniversitesi",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60012603",
            "affiliation-country": "Turkey"
        },
        {
            "affiliation-city": "Oslo",
            "@id": "60010348",
            "affilname": "Universitetet i Oslo",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60010348",
            "affiliation-country": "Norway"
        },
        {
            "affiliation-city": "Sao Paulo",
            "@id": "60008088",
            "affilname": "Universidade de S\u00e3o Paulo",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60008088",
            "affiliation-country": "Brazil"
        },
        {
            "affiliation-city": "Wroclaw",
            "@id": "60007108",
            "affilname": "Wroclaw Medical University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60007108",
            "affiliation-country": "Poland"
        },
        {
            "affiliation-city": "Rochester",
            "@id": "60005558",
            "affilname": "Mayo Clinic",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60005558",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Porto",
            "@id": "60003102",
            "affilname": "Instituto Portugues de Oncologia de Francisco Gentil Porto",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60003102",
            "affiliation-country": "Portugal"
        },
        {
            "affiliation-city": "Boston",
            "@id": "60002746",
            "affilname": "Harvard Medical School",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002746",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Atlanta",
            "@id": "60002339",
            "affilname": "Emory University School of Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002339",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Barcelona",
            "@id": "60001576",
            "affilname": "Universitat de Barcelona",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60001576",
            "affiliation-country": "Spain"
        },
        {
            "affiliation-city": "Dresden",
            "@id": "118307450",
            "affilname": "BAG Freiberg-Richter",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/118307450",
            "affiliation-country": "Germany"
        },
        {
            "affiliation-city": "Sao Paulo",
            "@id": "107071786",
            "affilname": "Cl\u00ednica S\u00e3o Germano",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/107071786",
            "affiliation-country": "Brazil"
        },
        {
            "affiliation-city": "Barretos",
            "@id": "106564520",
            "affilname": "Hospital do C\u00e2ncer de Barretos. Funda\u00e7\u00e3o Pio XII (FP)",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/106564520",
            "affiliation-country": "Brazil"
        }
    ],
    "funding": [
        "IDDI",
        "Ken Shain",
        "Levine Cancer Institute",
        "Secura Bio",
        "Novartis",
        "Novartis"
    ]
}